Axa’s Prothena Corp PRTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-120,630
| Closed | -$1.67M | – | 1125 |
|
|
2024
Q4 | $1.67M | Sell |
120,630
-125
| -0.1% | -$1.97K | 0.01% | 790 |
|
|
2024
Q3 | $2.02M | Buy |
120,755
+36
| +0% | +$774 | 0.01% | 744 |
|
|
2024
Q2 | $2.49M | Buy |
120,719
+69
| +0.1% | +$1.49K | 0.01% | 708 |
|
|
2024
Q1 | $2.99M | Buy |
120,650
+33
| +0% | +$982 | 0.01% | 680 |
|
|
2023
Q4 | $4.38M | Buy |
120,617
+7,704
| +7% | +$297K | 0.01% | 580 |
|
|
2023
Q3 | $5.45M | Sell |
112,913
-403
| -0.4% | -$23.9K | 0.02% | 510 |
|
|
2023
Q2 | $7.74M | Buy |
113,316
+94,364
| +498% | +$6.09M | 0.03% | 458 |
|
|
2023
Q1 | $919K | Sell |
18,952
-900
| -5% | -$47.5K | ﹤0.01% | 880 |
|
|
2022
Q4 | $1.2M | Sell |
19,852
-32,373
| -62% | -$1.9M | ﹤0.01% | 857 |
|
|
2022
Q3 | $3.17M | Buy |
52,225
+25,900
| +98% | +$819K | 0.01% | 670 |
|
|
2022
Q2 | $715K | Sell |
26,325
-8,775
| -25% | -$257K | ﹤0.01% | 924 |
|
|
2022
Q1 | $1.28M | Buy |
+35,100
| New | +$1.27M | ﹤0.01% | 912 |
|
|
2021
Q3 | – | Sell |
-79,660
| Closed | -$4.09M | – | 1304 |
|
|
2021
Q2 | $4.09M | Sell |
79,660
-88,389
| -53% | -$2.76M | 0.01% | 753 |
|
|
2021
Q1 | $4.22M | Sell |
168,049
-7,800
| -4% | -$147K | 0.01% | 735 |
|
|
2020
Q4 | $2.11M | Hold |
175,849
| – | – | 0.01% | 843 |
|
|
2020
Q3 | $1.76M | Hold |
175,849
| – | – | 0.01% | 842 |
|
|
2020
Q2 | $1.84M | Sell |
175,849
-6,160
| -3% | -$68.4K | 0.01% | 842 |
|
|
2020
Q1 | $1.95M | Buy |
182,009
+35,300
| +24% | +$428K | 0.01% | 742 |
|
|
2019
Q4 | $2.32M | Hold |
146,709
| – | – | 0.01% | 780 |
|
|
2019
Q3 | $1.15M | Buy |
146,709
+43,286
| +42% | +$385K | ﹤0.01% | 964 |
|
|
2019
Q2 | $1.09M | Buy |
103,423
+75,963
| +277% | +$780K | ﹤0.01% | 957 |
|
|
2019
Q1 | $333K | Hold |
27,460
| – | – | ﹤0.01% | 1173 |
|
|
2018
Q4 | $283K | Hold |
27,460
| – | – | ﹤0.01% | 1182 |
|
|
2018
Q3 | $359K | Hold |
27,460
| – | – | ﹤0.01% | 1202 |
|
|
2018
Q2 | $400K | Sell |
27,460
-115,421
| -81% | -$2.28M | ﹤0.01% | 1176 |
|
|
2018
Q1 | $5.25M | Sell |
142,881
-1,437
| -1% | -$52.3K | 0.02% | 635 |
|
|
2017
Q4 | $5.41M | Sell |
144,318
-147
| -0.1% | -$7.48K | 0.02% | 625 |
|
|
2017
Q3 | $9.36M | Sell |
144,465
-2,012
| -1% | -$123K | 0.04% | 454 |
|
|
2017
Q2 | $7.93M | Sell |
146,477
-5,452
| -4% | -$291K | 0.04% | 488 |
|
|
2017
Q1 | $8.48M | Sell |
151,929
-4,613
| -3% | -$242K | 0.04% | 459 |
|
|
2016
Q4 | $7.7M | Buy |
156,542
+2,971
| +2% | +$164K | 0.04% | 473 |
|
|
2016
Q3 | $9.21M | Sell |
153,571
-30,205
| -16% | -$1.62M | 0.04% | 425 |
|
|
2016
Q2 | $6.42M | Sell |
183,776
-7,509
| -4% | -$327K | 0.03% | 513 |
|
|
2016
Q1 | $7.87M | Sell |
191,285
-8,113
| -4% | -$318K | 0.04% | 445 |
|
|
2015
Q4 | $13.6M | Buy |
199,398
+17,522
| +10% | +$1.06M | 0.06% | 311 |
|
|
2015
Q3 | $8.25M | Buy |
181,876
+130,714
| +255% | +$7.61M | 0.03% | 431 |
|
|
2015
Q2 | $2.69M | Buy |
+51,162
| New | +$2.02M | 0.01% | 729 |
|
Other funds holding PRTA
EC
AC
PAI
SL
Axa's PRTA Position: Q1 2025 in Review
Axa sold out of Prothena Corp (PRTA) in Q1 2025, closing a stake of 120,630 shares — an estimated $1.67M sold.
Axa first reported a position in PRTA in Q2 2015 and held it in 37 quarters. The position peaked at $13.6M in Q4 2015. 161 funds tracked by Wall St. Rank hold PRTA as of Q1 2025.
- Axa reported no remaining Prothena Corp position as of Q1 2025 after selling out during the quarter.
- Axa sold 120,630 Prothena Corp shares in Q1 2025, an estimated $1.67M.
- Axa first reported a position in Prothena Corp in Q2 2015 and held it in 37 quarters.
- Axa's Prothena Corp position peaked at $13.6M in Q4 2015.
- 161 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2025.
Based on Axa's 13F filing for Q1 2025, filed 15 May 2025.